IL17A and metabolic dysfunction-associated steatotic liver disease: The lack of IL-17 in various MASLD murine models was associated with increased fat accumulation in the liver (Figure 1), affecting mainly the expression of stearoyl-CoA desaturase-1 (SCD-1), a regulator of lipogenesis (132, 145–147).